Arix Bioscience PLC Investor Relations Material
Latest events
Investor Update
Arix Bioscience PLC
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Arix Bioscience PLC
Access all reports
Arix Bioscience PLC is a global venture capital company investing in biotechnology companies. It focuses on cutting-edge advances in life sciences, aiming to accelerate the development of new treatments for patients. Arix Bioscience works closely with exceptional entrepreneurs, providing not only capital but also expertise and access to global networks. The company has a diversified investment portfolio that includes companies working on therapies for oncology, orphan diseases, infectious diseases, and gene therapies. Arix Bioscience's model is to source, finance, and develop these innovative technologies, taking an active role in their portfolio companies by often taking board seats to support growth and clinical success. Arix Bioscience is headquartered in London, UK, and its shares are listed on the London Stock Exchange.
Latest articles
The World of Luxury: Creating and Selling Desirability
Dive into the enchanting world of high-end allure, where the art of exclusivity shapes desire, turning luxury into an emblem of unique prestige.
6 May 2024
Companies That Had Their IPO in 2019: Bull Market and Tech Dominance
Discussing the stock and IPO market in 2019, and the factors that led to the overall bullish performance of stocks during the year.
3 May 2024
Microsoft's Journey to Becoming the World's Most Valuable Company
Explore Microsoft's rise from a garage startup to the world's most valuable company, highlighting Bill Gates' role in shaping the digital revolution.
3 May 2024
Ticker symbol
Country
đŹđ§ United Kingdom